Core Insights - Ant Group's CEO, Han Xinyi, emphasized the importance of specialized AI models in the healthcare sector, stating that general models cannot easily replace them due to the unique requirements of medical applications [1][3] - The company aims to address critical issues such as data quality, hallucination suppression, and medical ethics to enhance AI's role as a supportive tool for doctors rather than a replacement [4][5] Group 1: AI in Healthcare - Ant Group is focusing on AI in healthcare due to the dual characteristics of "urgent need + high frequency," combining low-frequency medical actions with high-frequency health management [3] - The ultimate goal of AI in healthcare is to provide personalized, precise, and reliable recommendations akin to those of professional doctors, which general models will struggle to achieve for a considerable time [3][4] Group 2: Challenges in AI Implementation - High-quality data is fundamental, with costs for data labeling and training potentially exceeding hundreds of dollars per data point, requiring involvement from senior medical experts to ensure quality [4] - Suppressing hallucinations in AI models is challenging, as it requires balancing error reduction without compromising service capability [4] - Medical ethics is a complex issue, prompting Ant Group to establish a Medical Ethics Advisory Committee to explore regulations collaboratively with top experts in the field [4] Group 3: Market Position and Future Plans - The healthcare market is valued at trillions, but Ant Group is not rushing into commercialization; instead, it is prioritizing the accumulation of professional data, hallucination suppression, and ethical considerations [4][5] - As of June 2023, Ant Group launched the AI Health Manager AQ, which has served over 140 million users, connected with more than 5,000 hospitals, and assisted nearly 100,000 real doctors [5]
蚂蚁集团CEO韩歆毅：让AI成为医生的好助手